$138.90
3.12% today
Nasdaq, Jul 18, 10:00 pm CET
ISIN
US6323071042
Symbol
NTRA
Sector
Industry

Natera, Inc. Stock price

$143.38
-24.17 14.43% 1M
-14.98 9.46% 6M
-14.92 9.43% YTD
+33.01 29.91% 1Y
+99.80 229.00% 3Y
+95.28 198.09% 5Y
+122.50 586.69% 10Y
+120.64 530.52% 20Y
Nasdaq, Closing price Thu, Jul 17 2025
-5.02 3.38%
ISIN
US6323071042
Symbol
NTRA
Sector
Industry

Key metrics

Basic
Market capitalization
$19.6b
Enterprise Value
$18.7b
Net debt
positive
Cash
$991.6m
Shares outstanding
135.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
10.7 | 9.6
EV/Sales
10.2 | 9.2
EV/FCF
219.1
P/B
15.8
Financial Health
Equity Ratio
72.0%
Return on Equity
-15.9%
ROCE
-16.6%
ROIC
-33.9%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$1.8b | $2.0b
EBITDA
$-194.0m | $-315.2m
EBIT
$-227.2m | $-353.8m
Net Income
$-189.8m | $-305.0m
Free Cash Flow
$85.2m
Growth (TTM | estimate)
Revenue
51.5% | 19.8%
EBITDA
45.5% | -64.7%
EBIT
40.6% | -59.2%
Net Income
48.1% | -60.1%
Free Cash Flow
143.1%
Margin (TTM | estimate)
Gross
61.8%
EBITDA
-10.6% | -15.5%
EBIT
-12.4%
Net
-10.4% | -15.0%
Free Cash Flow
4.7%
More
EPS
$-1.4
FCF per Share
$0.6
Short interest
4.8%
Employees
4k
Rev per Employee
$380.0k
Show more

Is Natera, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.

Natera, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Natera, Inc. forecast:

25x Buy
96%
1x Hold
4%

Analyst Opinions

26 Analysts have issued a Natera, Inc. forecast:

Buy
96%
Hold
4%

Financial data from Natera, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,831 1,831
52% 52%
100%
- Direct Costs 700 700
16% 16%
38%
1,131 1,131
86% 86%
62%
- Selling and Administrative Expenses 914 914
38% 38%
50%
- Research and Development Expense 445 445
36% 36%
24%
-194 -194
46% 46%
-11%
- Depreciation and Amortization 33 33
27% 27%
2%
EBIT (Operating Income) EBIT -227 -227
41% 41%
-12%
Net Profit -190 -190
48% 48%
-10%

In millions USD.

Don't miss a Thing! We will send you all news about Natera, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Natera, Inc. Stock News

Neutral
Business Wire
11 days ago
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced data from a colorectal cancer (CRC) study of its tissue-free Latitude™ MRD assay, which were presented at the 2025 European Society for Medical Oncology GI Congress (ESMO GI). The clinical performance of the assay was analyzed in a cohort of ~200 patients (>1,300...
Neutral
Business Wire
17 days ago
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, announced new data that will be presented at the 2025 European Society for Medical Oncology GI Congress (ESMO GI) in Barcelona, Spain. These presentations reinforce the strong clinical and economic utility of Signatera™ monitoring across colon and rectal cancers (CRC), as well a...
Positive
24/7 Wall Street
about one month ago
A high-growth gem is the largest holding in Stanley Druckenmiller's firm's fund.
More Natera, Inc. News

Company Profile

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.

Head office United States
CEO Stephen Chapman
Employees 4,429
Founded 2004
Website www.natera.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today